1 – 25 of 25
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
(
- Contribution to journal › Article
- 2021
-
Mark
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
(
- Contribution to journal › Article
- 2020
-
Mark
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
(
- Contribution to journal › Article
-
Mark
SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP
(
- Contribution to journal › Article
-
Mark
A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival
(
- Contribution to journal › Article
- 2019
-
Mark
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
(
- Contribution to journal › Article
- 2017
-
Mark
The HDAC inhibitor valproate induces a bivalent status of the CD20 promoter in CLL patients suggesting distinct epigenetic regulation of CD20 expression in CLL in vivo
(
- Contribution to journal › Article
- 2016
-
Mark
Different expression levels of glycans on leukemic cells—a novel screening method with molecularly imprinted polymers (MIP) targeting sialic acid
(
- Contribution to journal › Article
- 2013
-
Mark
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
(
- Contribution to journal › Article
-
Mark
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
(
- Contribution to journal › Article
- 2012
-
Mark
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
(
- Contribution to journal › Article
-
Mark
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles
(
- Contribution to journal › Article
-
Mark
IGHV3-21 Gene Frequency in a Swedish Cohort of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
(
- Contribution to journal › Article
- 2011
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2010
-
Mark
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
Array based genetic profiling of chronic lymphocytic leukemia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Endoplasmic reticulum stress associated with caspases-4 and-2 mediates korbazol-induced B-chronic lymphocytic leukemia cell apoptosis
(
- Contribution to journal › Article
-
Mark
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2009
-
Mark
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2008
-
Mark
The BCL-2 promoter (-938C > A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2001
-
Mark
Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion
(
- Contribution to journal › Article